Skip to main content
Log in

Prognostic importance of DNA flow cytometrical, histopathological and immunohistochemical parameters in neuroblastomas

  • Original Articles
  • Published:
Virchows Archiv A Aims and scope Submit manuscript

Summary

In 42 tumour samples of human neuroblastoma, histological classification by differentiation (Shimada) was significantly correlated with strong positivity for neuron-specific enolase (NSE) and inversely correlated with rosette formation. Most ganglioneuroblastomas were positive for S-100 protein and reacted strongly with NSE antibody. Histological signs of high proliferative activity included intermediate or high mitosis-karyorrhexis index, necrosis and lack of calcification, which were significantly correlated with each other. Flow cytometric DNA analysis demonstrated that 88% of the tumour samples had DNA aneuploid stem lines. High S phase fraction (>-0.20) was significantly correlated with necrosis and lack of calcification. Univariate analysis of prognosis for 26 patients whose tumour samples were obtained before adjuvant treatment showed that five factors were significantly related to a better outcome: early stage of the disease (stages I, II, IV-S), S phase fraction <0.20, favourable Shimada histology, positivity for S-100 protein, and strong positivity for NSE. In multivariate analysis, only S phase fractionor stage of disease remained significantly associated with prognosis. DNA index did not correlate with prognosis in this study.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Alanen KA, Joensuu H, Klemi PJ (1989) Autolysis is a potential source of false aneuploid peaks in flow cytometric DNA histograms. Cytometry 10:417–425

    Google Scholar 

  • Anderson JR, Cain KC, Gelber RD, Gelman RS (1985) Analysis and interpretation of the comparison of survival by treatment outcome variables in cancer clinical trials. Cancer Treat Rep 69:1139–1146

    Google Scholar 

  • Aoyama C, Qualman SJ, Regan M, Shimada H (1990) Histopathologic features of composite ganglioneuroblastoma. Cancer 65:255–264

    Google Scholar 

  • Beckwith JB, Martin RF (1968) Observations on the histopathology of neuroblastomas. J Pediatr Surg 3:106–110

    Google Scholar 

  • Biedler JL, Reynolds CP, Ross RA, Mirkin BL, Tsunamoto K, Sugimoto T, Boyd JP (1988) Discussion. In: Evans AE, D'Angio GJ, Knudson AG, Seeger RC (eds) Advances in neuroblastoma research 2. Liss, New York, pp 359–375

    Google Scholar 

  • Bourhis J, De Vathaire F, Wilson GD, Hartman O, Terrier-Lacombe MJ, Boccon-Gibod L, McNally NJ, Lemerle J, Riou G, Bénard J (1991) Combined analysis of DNA ploidy index and N-myc genomic content in neuroblastoma. Cancer Res 51:33–36

    Google Scholar 

  • Brenner DW, Barranco SC, Winslow BH, Shaeffer J (1989) Flow cytometric analysis of DNA content in children with neuroblastoma. J Pediatr Surg 24:204–207

    Google Scholar 

  • Breslow N, McCann B (1971) Statistical estimation of prognosis for children with neuroblastoma. Cancer Res 31:2098–2103

    Google Scholar 

  • Brodeur GM, Fong C-t (1989) Molecular biology and genetics of human neuroblastoma. Cancer Genet Cytogenet 41:153–174

    Google Scholar 

  • Brown P de Nully, Hertz H, Olsen JH, Yssing M, Scheibel E, Jensen OM (1989) Incidence of childhood cancer in Denmark 1943-1984. Int J Epidemiol 18:546–555

    Google Scholar 

  • Carlei F, Polak JM, Ceccamea A, Marangos PJ, Dahl D, Cocchia D, Michetti F, Lezoche E, Speranza V (1984) Neuronal and glial markers in tumours of neuroblastic origin. Virchows Arch [A] 404:313–324

    Google Scholar 

  • Carlsen NLT (1991a) Maturation of neuroblastoma. Eur J Cancer 27:219

    Google Scholar 

  • Carlsen NLT (1991b) Prognostic factors in neuroblastomas of childhood. Current problems. Pediatr Rev Commun 6:63–77

    Google Scholar 

  • Carlsen NLT, Nielsen OH, Hertz H (1981) Neuroblastoma. Acta Paediatr Scand 70:61–66

    Google Scholar 

  • Carlsen NLT, Christensen IJ, Schroeder H, Bro PV, Erichsen G, Hamborg-Pedersen B, Jensen KB, Nielsen OH (1986) Prognostic factors in neuroblastomas treated in Denmark from 1943 to 1980. Cancer 58:2726–2735

    Google Scholar 

  • Carlsen NLT, Mortensen BT, Andersson PK, Larsen JK, Nielsen OH, Tommerup N (1991) Chromosome abnormalities, cellular DNA content, oncogene amplification, and growth pattern in agar culture of human neuroblastoma. Anticancer Res 11:353–358

    Google Scholar 

  • Christensen I, Hartmann NR, Keiding N, Larsen JK, Noer H, Vindetøv L (1978) Statistical analysis of DNA distribution from cell populations with partial synchrony. In: Lutz D (ed) Pulsecytophotometry III. European Press, Ghent, pp 71–78

    Google Scholar 

  • Cohn SL, Rademaker AW, Salwen HR, Franklin WA, Gonzales-Crussi F, Rosen ST, Bauder KD (1990) Analysis of DNA ploidy and proliferative activity in relation to histology and N-myc amplification in neuroblastoma. Am J Pathol 136:1043–1052

    Google Scholar 

  • Coldman AJ, Fryer CJH, Elwood JM, Sonley MJ (1980) Neuroblastoma: influence of age at diagnosis, stage, tumor site, and sex on prognosis. Cancer 46:1896–1901

    Google Scholar 

  • Dargeon HW (1962) Neuroblastoma. J Pediatr 61:456–471

    Google Scholar 

  • Evans AE, D'Angio GJ, Propert K, Anderson J, Hann H-WL (1987) Prognostic factors in neuroblastoma. Cancer 59:1853–1859

    Google Scholar 

  • Evans AE, D'Angio GJ, Sather HN, deLorimier AA, Dalton A, Ungerleider RS, Finklestein JZ, Hammond GD (1990) A comparison of four staging systems for localized and regional neuroblastoma: a report from the Childrens Cancer Study Group. J Clin Oncol 8:678–688

    Google Scholar 

  • Gansler T, Chatten J, Varello M, Bunin GR, Atkinson B (1986) Flow cytometric DNA analysis of neuroblastoma. Correlation with histology and clinical outcome. Cancer 58:2453–2458

    Google Scholar 

  • Gitlow SE, Dziedzic LB, Strauss L, Greenwood SM, Dziedzic SW (1973) Biochemical and histologic determinants in the prognosis of neuroblastoma. Cancer 32:898–905

    Google Scholar 

  • Haase GM, Wong KY, deLorimier AA, Sather HN, Hammond GD (1989) Improvement in survival after excision of primary tumor in stage III neuroblastoma. J Pediatr Surg 24:194–200

    Google Scholar 

  • Hayashi Y, Kanda N, Inaba T, Hanada R, Nagahara N, Muchi H, Yamamoto K (1989) Cytogenetic findings and prognosis in neuroblastoma with emphasis on marker chromosome 1. Cancer 63:126–132

    Google Scholar 

  • Horn RC, Koop CE, Kiesewetter WB (1956) Neuroblastoma in childhood. Clinicopathologic study of forty-four cases. Lab Invest 5:106–119

    Google Scholar 

  • Hughes M, Marsden HB, Palmer MK (1974) Histologic patterns of neuroblastoma related to prognosis and clinical staging. Cancer 34:1706–1711

    Google Scholar 

  • Kaneko Y, Kanda N, Maseki N, Sakurai M, Tsuchida Y, Takeda T, Okabe I, Sakurai M (1987) Different karyotypic patterns in early and advanced stage neuroblastomas. Cancer Res 47:311–318

    Google Scholar 

  • Look AT, Hayes FA, Nitschke R, McWilliams NB, Green AA (1984) Cellular DNA content as a predictor of response to chemotherapy in infants with unresectable neuroblastoma. N Engl J Med 311:231–235

    Google Scholar 

  • Look AT, Hayes FA, Shuster JJ, Douglass EC, Castleberry RP, Bowman LC, Smith El, Brodeur GM (1991) Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study. J Clin Oncol 9:581–591

    Google Scholar 

  • Mäkinen J (1972) Microscopic patterns as a guide to prognosis of neuroblastoma in childhood. Cancer 29:1637–1646

    Google Scholar 

  • Matthay KK, Sather HN, Seeger RC, Haase GM, Hammond GD (1989) Excellent outcome of stage II neuroblastoma is independent of residual disease and radiation therapy. J Clin Oncol 7:236–244

    Google Scholar 

  • Molenaar WM, Baker DL, Pleasure D, Lee V M-Y, Trojanowski JQ (1990) The neuroendocrine and neural profiles of neuroblastomas, ganglioneuroblastomas, and ganglioneuromas. Am J Pathol 136:375–382

    Google Scholar 

  • Nitschke R, Smith EI, Shochat S, Altshuler G, Travers H, Shuster JJ, Hayes FA, Patterson R, McWilliams N (1988) Localized neuroblastoma treated by surgery: a Pediatric Oncology Group study. J Clin Oncol 6:1271–1279

    Google Scholar 

  • O'Neill JA, Littman P, Blitzer P, Soper K, Chatten J, Shimada H (1985) The role of surgery in localized neuroblastoma. J Pediatr Surg 20:708–712

    Google Scholar 

  • Oppedal BR, Storm-Mathisen I, Lie SO, Brandtzaeg P (1988) Prognostic factors in neuroblastoma. Clinical, histopathologic, and immunohistochemical features and DNA ploidy in relation to prognosis. Cancer 62:772–780

    Google Scholar 

  • Ornvold K, Carstensen H, Larsen JK, Christensen IJ, Ralfkiaer E (1990) Flow cytometric DNA analysis of lesions from 18 children with Langerhans cell histiocytosis (Histiocytosis X). Am J Pathol 136:1301–1307

    Google Scholar 

  • Sandstedt B, Jereb B, Eklund G (1983) Prognostic factors in neuroblastomas. APMIS 91:365–371

    Google Scholar 

  • Schutte B, Reynders MMJ, Bosman FT, Blijham GH (1985) Flow cytometric determination of DNA ploidy level in nuclei isolated from paraffin-embedded tissue. Cytometry 6:26–30

    Google Scholar 

  • Shimada H, Chatten J, Newton WA, Sachs N, Hamoudi AB, Chiba T, Marsden HB, Misugi K (1984) Histopathologic prognostic factors in neuroblastic tumors: definitions of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J Natl Cancer Inst 73:405–416

    Google Scholar 

  • Shimada H, Aoyama C, Chiba T, Newton WA (1985) Prognostic subgroups for undifferentiated neuroblastoma: immunohisto-chemical study with anti-S-100 protein antibody. Hum Pathol 16:471–476

    Google Scholar 

  • Slavc I, Ellenbogen R, Jung W-H, Vawter GF, Kretschmar C, Grier H, Korf BR (1990)Myc gene amplification and expression in primary human neuroblastoma. Cancer Res 50:1459–1463

    Google Scholar 

  • Suzuki H, Takeuchi K, Honzumi M (1989) Letter to the Editor. J Pediatr Surg 24:850

    Google Scholar 

  • Taylor SR, Locker J (1990) A comparative analysis of nuclear DNA content and N-myc gene amplification in neuroblastoma. Cancer 65:1360–1366

    Google Scholar 

  • Taylor SR, Blatt J, Costantino JP, Roederer M, Murphy RF (1988) Flow cytometric DNA analysis of neuroblastoma. A 10-year retrospective study. Cancer 62:749–754

    Google Scholar 

  • Thomas PRM, Lee JY, Fineberg BB, Razek AA, Perez CA, Land VJ, Vietti TJ (1984) An analysis of neuroblastoma at a single institution. Cancer 53:2079–2082

    Google Scholar 

  • Tsuda T, Obara M, Hirano H, Gotoh S, Kubomura S, Higashi K, Kuroiwa A, Nakagawara A, Nagahara N, Shimizu K (1987) Analysis of N-myc amplification in relation to disease stage and histologic types in human neuroblastomas. Cancer 60:820–826

    Google Scholar 

  • Vindeløv LL, Christensen IJ (1990) A review of techniques and results obtained in one laboratory by an integrated system of methods designed for routine clinical flow cytometric DNA analysis. Cytometry 11:753–770

    Google Scholar 

  • Wilson LMK, Draper GJ (1974) Neuroblastoma, its natural history and prognosis: a study of 487 cases. BMJ 3:301–307

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Carlsen, N.L.T., Ørnvold, K., Christensen, I.J. et al. Prognostic importance of DNA flow cytometrical, histopathological and immunohistochemical parameters in neuroblastomas. Vichows Archiv A Pathol Anat 420, 411–418 (1992). https://doi.org/10.1007/BF01600512

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01600512

Key words

Navigation